Corline Biomedical AB (STO:CLBIO)
19.00
+0.15 (0.80%)
Oct 10, 2025, 5:22 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 465.33 million as of October 10, 2025. Its market cap has increased by 176.88% in one year.
Market Cap
465.33M
Enterprise Value
457.00M
Revenue
10.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.00
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 465.33M, an increase of 374.99%. That is a compound annual growth rate of 16.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 465.33M | 146.61% |
Dec 30, 2024 | 188.69M | -41.07% |
Dec 29, 2023 | 320.21M | 61.61% |
Dec 30, 2022 | 198.15M | -36.85% |
Dec 30, 2021 | 313.77M | 25.86% |
Dec 30, 2020 | 249.29M | -0.33% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 103.82B |
Sectra AB | 58.15B |
Getinge AB | 56.27B |
Camurus AB | 41.07B |
Medicover AB | 39.41B |
Asker Healthcare Group AB | 32.35B |
BioArctic AB | 25.79B |
AddLife AB | 22.34B |